未登录

T

Thomas J. O'Keefe

University of California System

H指数:29

被引数:3,235

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Critique of the DCISionRT Test

对DCISionRT测试的批判

International Journal of Radiation Oncology Biology Physics

IF6.5

2026-08-010

PRE

Independent Relevance of Estrogen Receptor and Progesterone Receptor Statuses in DCIS on Risk of Subsequent Ipsilateral and Contralateral Invasive Breast Events in Absence of Endocrine Therapy

雌激素受体和孕激素受体状态在DCIS中与后续同侧和对侧浸润性乳腺癌事件风险的相关性（在缺乏内分泌治疗的情况下）

IF4.4

2026-04-030

OAAI

Relative Effects of Brachytherapy and Beam Radiation for DCIS on Subsequent Invasive Events

两种近距离放射治疗与外照射对DCIS术后侵袭性事件相对效果的比较

IF3.9

2026-03-030

OAAI

Active Surveillance of Ductal Carcinoma In-Situ

导管原位癌的主动监测

Current Breast Cancer Reports

IF0.9

2026-01-040

OA

Rethinking the Unplanned ICU Admission Quality Metric in Trauma Patients

AMERICAN SURGEON

IF0.9

2025-10-010

PRE

Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis

新辅助内分泌治疗对浸润性导管癌与浸润性小叶癌保乳手术效果的影响：一项比较分析

JOURNAL OF SURGICAL ONCOLOGY

IF1.9

2025-09-010

OAAI

Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second events

多机构注册研究的数据显示，内分泌治疗对DCIS的持续时间会影响二次事件的发生。

npj Breast Cancer

IF7.6

2025-07-010

OAAI

Reply to: Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-11-280

PRE

ASO Visual Abstract: Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70? A National Cancer Database (NCDB) Analysis of Sentinel Node Practice Patterns

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-08-260

OA

Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-07-256

OAAI

Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy

IF14.9

2023-06-010

PRE

Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence

IF2.7

2023-02-012

OAAI

Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2022-12-272

OAAI

The breast pre-cancer atlas illustrates the molecular and microenvironmental diversity of ductal carcinoma in situ

NPJ BREAST CANCER

IF7.6

2022-01-1312

OAAI

Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-11-122

OAAI

Genomic spatial profiling of archived pre-malignant lesions of the breast epithelium

CANCER RESEARCH

IF16.6

2020-08-150

PRE

HER2 positive DCIS increases short term risk of ipsilateral invasive ductal carcinoma in breast conserving surgery patients

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-06-114

PREAI

Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study

CANCER RESEARCH

IF16.6

2020-02-150

PRE

A high-sensitivity molecular profiling approach to spatially characterize archived pre-cancer lesions

CANCER RESEARCH

IF16.6

2020-02-150

PRE